South Africa begins first HIV vaccine trial in seven yearsBMJ 2016; 355 doi: https://doi.org/10.1136/bmj.i6501 (Published 01 December 2016) Cite this as: BMJ 2016;355:i6501
- Owen Dyer
The stalled search for an elusive vaccine against HIV began again on 30 November with the official start of the HVTN 702 trial in South Africa. The vaccine efficacy study will follow 5400 men and women injected over a year with five doses of either a two part vaccine or placebo. Results are due in 2020.
“HIV has taken a devastating toll in South Africa, but now we begin a …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial